We’re Moving! A New Home for StemCultures

150 new scotland avenue albany ny 12208

StemCultures is moving operations to a new facility, located on the 3rd floor of 150 New Scotland Avenue, Albany, NY 12208. Our new location is closer to Albany’s central healthcare facilities, collaborators, and local partners. We look forward to continuing to support your scientific discoveries as we transition into this new space. Thanks to our customers, we are able to move into facilities that will continue to support our growth.

About Our New Location

In June of 2022, 150 New Scotland Avenue’s state-of-the-art life sciences and medical building was acquired by the Albany College of Pharmacy and Health Sciences, which is one of the nation’s oldest and most established colleges of pharmacy. The acquisition expanded the adjacent college’s campus, naming the acquired property the Life Sciences and Innovation Building. The purchase allows the college’s mission of supporting the rapid growth of the biopharmaceutical industry to continue, further supporting student education and local life sciences companies. The combination of tenants will create synergies for contract research, employment growth, and workforce development.

The facility boasts over 60,000 square feet of biosafety level (BSL) 2 and BSL-3 research labs, of which StemCultures will occupy a fraction. Renovations to the facilities in 2023 now allow for dedicated gene therapy labs, teaching wet labs, biopharmaceutical pilot facilities, classrooms, and student lounges.

New Neighbors

StemCultures is also looking forward to working with their new neighbors. Located just across the street is the Albany College of Pharmacy and Health Sciences. One division of the college is even under the same roof as StemCultures. The Stack Family Center for Biopharmaceutical Education and Training, or CBET, is located on the 4th floor of the Life Sciences Innovation Building. The StemCultures team collaborated with CBET at the NIIMBL eXperience earlier this year, which immersed students in real-world and hands-on scenarios for the biopharmaceutical industry. StemCultures looks forward to working with them more in the future.

Also down the hall will be the Wadsworth Center, a New York State Department of Health laboratory. The scientists at the Center focus on investigating ongoing public health issues, such as bioterrorism cases, environmental exposure cases, and pandemics. They also develop analytical methods to detect targets ranging from microbes and environmental toxins to genetic disorders and biologically relevant molecules.

One of our neighbors is a familiar face, as the Neural Stem Cell Institute, and their NeuraCell CORE Facility, will still be down the hall from us. The CORE facility houses StemCulture’s research and development team along with providing contract research, production of high-quality cell lines, and other services for their customers. The group has over 20 years of experience working with various cell types including induced pluripotent stem cells, neural progenitor cells, and retinal pigment epithelial cells. NSCI is the first independent stem cell research institute in the country.

Logistics Information

StemCultures will begin moving in September and expects to be fully operational in the new facility by October 11, 2024. As StemCultures transitions operations, customers are advised there may be up to a 3 week delay in orders placed after September 24th until we are fully operational. Customers will be notified after placing their order if any delays are expected.

All mail and deliveries (including payments made by check) should now be addressed to:

StemCultures, LLC
150 New Scotland Avenue
Albany, NY 12208

StemCultures’s other contact information will remain the same (see below). Please reach out with any questions regarding our upcoming move.

www.stemcultures.com
+1 (518)-621-0848
support@stemcultures.com

Though we are leaving Discovery Dr., we look forward to continuing to discover new controlled-release growth factor formulations so that our customers can continue to discover new and meaningful cell therapies.